International Clinical Trial: In high-grade serous ovarian cancer, excessive lactatization leads to cytoskeletal aggregation, which downregulates the pathway driving amoeboid movement and blocks autophagy, thereby increasing the invasiveness of malignant tumors

Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126467) titled 'In high-grade serous ovarian cancer, excessive lactatization leads to cytoskeletal aggregation, which downregulates the pathway driving amoeboid movement and blocks autophagy, thereby increasing the invasiveness of malignant tumors' on June 9.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: The First Affiliated Hospital of Chongqing Medical University

Condition: High-grade serous ovarian carcinoma (HGSOC)

Intervention: Disease group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-30

Target Sample Size: Disease group:4;Control Group:4; ...